5 Questions with Kurt Elam, Senior Director, Sales & Marketing for LabOwl

Published on :

Kurt Elam joined ACC/Lab Owl in 2017 with 20+ years of specialty biopharmaceutical experience, focused primarily on oncology, infectious disease, and critical care/ICU medicine. He has overseen and managed the successful launch of over 16 new FDA approved products/compounds or new indications, and worked to gain formulary approval in managed care organizations, thereby improving access for patients.

5 Questions with Chad Schneider, PE, MSE, President & Founder of Root3 Labs

Published on :

Mr. Schneider is a mechanical design engineer with over 20 years of engineering experience in the design of complex electromechanical prototypes and products. He earned a BS in mechanical engineering with Honors from the University of Maryland, College Park, and a MSE in mechanical engineering from Johns Hopkins University with a focus on haptics and medical robotics. In 2012, he founded Root3 Labs to focus on practical R&D for the medical device and defense industries.

5 Questions with Ken Malone, Co-Founder, and Principal, Early Charm Ventures, LLC.

Published on :

Ken Malone is a co-founder of Early Charm Ventures, a venture studio founded in 2012 in Baltimore (Charm City) that converts science to business. Early Charm specializes in taking brilliant scientific discoveries made at universities and turning them into companies focused on growth. They don’t chase quick exits. They build companies that create sustainable value.

5 Questions with John Newby, CEO, Virginia Bio

Published on :

John Newby is the CEO at Virginia Bio, the statewide non-profit trade association for the life science industry. Approximately 300 companies spanning biopharmaceuticals, medical devices, med tech, diagnostics, digital health, bioinformatics, agriculture, and industrial bio and related fields are based in Virginia, mainly clustered around research universities and medical institutions. Virginia Bio is the sole state affiliate and works closely with key national industry organizations BIO, AdvaMed, MDMA, PhRMA and We Work for Health.

5 Questions with Martha Schoonmaker, Executive Director, Pinkney Innovation Complex for Science and Technology at Montgomery College (PIC MC)

Published on :

Martha Schoonmaker is the first Executive Director for the PIC MC Foundation, the entity that develops, manages and markets the Germantown campus on behalf of Montgomery College for company locations. PIC MC is an integrated academic, business, and research campus and is the only community college with a hospital, Holy Cross Germantown Hospital, located as the anchor resident partner.

5 Questions with Brian Hahn, Senior Vice President & CFO, GlycoMimetics

Published on :

Mr. Hahn has more than 15 years of senior financial and operations experience in emerging organizations. He joined GlycoMimetics in 2010. Previously, Mr. Hahn served as executive director of finance at Middlebrook Pharmaceuticals (formerly Advancis Pharmaceutical), a publicly-traded specialty pharmaceutical company.

5 Questions with Amy Adams, Executive Director of the Institute for Biohealth Innovation at George Mason University

Published on :

As Executive Director of the Institute for Biohealth Innovation at George Mason University, Amy Adams is responsible for nurturing and advancing biohealth research and innovation interests of more than 250 faculty and thousands of students who represent a broad range of academic disciplines. Her role includes fostering partnerships with industry, healthcare, government, and academic partners.

5 Questions with Mike O’Mara, VP of Industrial Business Services, Miltenyi Biotec

Published on :

Mike O’Mara has more than 27 years of experience in biopharmaceutical contract manufacturing encompassing microbial, mammalian, and cell/Gene therapy manufacturing processes ranging from Preclinical/Phase I through Commercial.

Virtual DC Startup Showcase @ GW

Published on :

The George Washington University (GW) Technology Commercialization Office is pleased to host the inaugural DC Startup Showcase.DC Startup Showcase will present companies developing disruptive healthcare innovations. Log on to our [….]

Veteran Biotech Founder Marco Chacon Joins Industry Leaders to Teach High School Students about Careers in Biotech in Virtual Lecture Series

Published on :

Marco Chacon, the former Paragon Bioservices, now Catalent Gene Therapy, founder was among the top industry leaders who participated in a unique biotech workforce lecture series this past Summer.